Triazolopyridine compounds useful as dgat1 inhibitors

A compound according to Formula (I):

• or stereoisomers or salts thereof, wherein:
• A is alkyl, cycloalkyl, heterocyclyl, aryl, —C(O)R4, —C(O)OR4, or —C(O)NR4R5;
• R1 and R2 are independently hydrogen, alkyl, —(CH2)n-(cycloalkyl), —(CH2)n-(aryl), —(CH2)n-(heterocyclyl), aryl, and/or heterocyclyl, or R1 and R2 together with the carbon atom to which they are attached, form a 3- to 7-membered cycloalkyl or 4- to 7-membered heterocyclyl ring with one or two heteroatoms;
• n is an integer in the range of zero to 4;
• R3 is hydrogen or alkyl;
• R4 is alkyl, cycloalkyl, heterocyclyl, or aryl;
• and
• R5 is hydrogen or alkyl, or R4 and R5 together with the nitrogen atom to which they are attached, form a 4- to 7-membered heterocyclyl ring with one or two heteroatoms;
• wherein:
• each of said alkyl is substituted with 0-3 Ra;
• each of said cycloalkyl is substituted with 0-3 Ra;
• each of said heterocyclyl is substituted with 0-4 Rb;
• and
• each of said aryl is substituted with 0-4 Rb;
• Ra is, independently at each occurrence, F, Cl, Br, —CF3, —OH, —CN, —NRcRd, and/or C1-C3alkoxy;
• Rb is, independently at each occurrence, C1-C4alkyl, F, Cl, Br, —CF3, —OH, —CN, —NRcRd, and/or C1-C3alkoxy;
• and
• Rc and Rd are, independently at each occurrence, H and/or C1-C4alkyl, or Rc and Rd together with the nitrogen atom to which they are attached, form a 4- to 7-membered heterocyclyl ring with one or two heteroatoms.